Beneficial effects of genistein in suppression of proliferation, inhibition of metastasis, and induction of apoptosis in PC3 prostate cancer cells

References

• Banerjee, S., et al., 2008. Multi-targeted therapy of cancer by genistein. Cancer letters, 269 (2), 226–242.
   PubMed Web of Science ®Google Scholar
• Bauvois, B., 2012. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumorprogression. Biochimica et biophysica acta (bba) - reviews on cancer, 1825, 29–36.
   PubMed Web of Science ®Google Scholar
• Braselmann, H., et al., 2015. CFAssay: statistical analysis of the colony formation assay. Radiation oncology, 10, 223.
   PubMed Web of Science ®Google Scholar
• Casey, S.C., et al., 2015. Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in cancer biology, 35, S199–S223.
   PubMed Web of Science ®Google Scholar
• Choi, E.J., Jung, J.Y., and Kim, G.H., 2014. Genistein inhibits the proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation of ERalpha expression and induction of apoptosis. Experimental and therapeutic medicine, 8 (2), 454–458.
   PubMed Web of Science ®Google Scholar
• Chou, R.H., et al., 2013. Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-kappaB signaling pathway. Plos one, 8 (8), e71983.
   PubMed Web of Science ®Google Scholar
• Cuadrado, A., and Nebreda, A.R., 2010. Mechanisms and functions of p38 MAPK signalling. Biochemical journal, 429 (3), 403–417.
   PubMed Web of Science ®Google Scholar
• Cui, S., et al., 2017. Genistein inhibits the growth and regulates the migration and invasion abilities of melanoma cells via the FAK/paxillin and MAPK pathways. Oncotarget, 8, 21674–21691.
   PubMedGoogle Scholar
• Elmore, S., 2007. Apoptosis: a review of programmed cell death. Toxicologic pathology, 35 (4), 495–516.
   PubMed Web of Science ®Google Scholar
• Gregoraszczuk, E.L., et al., 2015. Effect of chemotherapeutic drugs on caspase-3 activity, as a key biomarker for apoptosis in ovarian tumor cell cultured as monolayer. A pilot study. Iranian journal of pharmaceutical research, 14 (4), 1153–1161.
   PubMed Web of Science ®Google Scholar
• Hsu, A., et al., 2010. Differential effects of wholesoy extract and soy isoflavones on apoptosis in prostate cancer cells. Experimental biology and medicine, 235 (1), 90–97.
   PubMed Web of Science ®Google Scholar
• Huang, W., et al., 2014. Genistein-inhibited cancer stem cell-like properties and reduced chemoresistance of gastric cancer. International journal of molecular sciences, 15 (3), 3432–3443.
   PubMed Web of Science ®Google Scholar
• Kim, J.J., et al., 2014. Nobiletin suppresses MMP-9 expression through modulation of p38 MAPKactivity in human dermal fibrobalsts. Biological and pharmaceutical bulletin, 37, 158–163.
   PubMed Web of Science ®Google Scholar
• Kim, E.K., and Choi, E.J., 2015. Compromised MAPK signaling in human diseases: an update. Archives of toxicology, 89 (6), 867–882.
   PubMed Web of Science ®Google Scholar
• Li, H.Q., Luo, Y., and Qiao, C.H., 2012. The mechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone. Mini reviews in medicinal chemistry, 12 (4), 350–362.
   PubMed Web of Science ®Google Scholar
• Liang, C.C., Park, A.Y., and Guan, J.L., 2007. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature protocols, 2 (2), 329–333.
   PubMed Web of Science ®Google Scholar
• Liu, Z., et al., 2017. Chemosensitizing effect of Paris Saponin I on Camptothecin and 10-hydroxycamptothecin in lung cancer cells via p38 MAPK, ERK, and Akt signaling pathways. European journal of medicinal chemistry, 125, 760–769.
   PubMed Web of Science ®Google Scholar
• Lu, S., et al., 2017. Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway. Oncology letters, 14, 7577–7582.
   PubMed Web of Science ®Google Scholar
• Luo, Y., et al., 2014. Apoptotic effect of genistein on human colon cancer cells via inhibiting the nuclear factor-kappa B (NF-kappaB) pathway. Tumor biology, 35 (11), 11483–11483.
   PubMedGoogle Scholar
• Maru, G.B., 2016. Understanding the molecular mechanisms of cancer prevention by dietary phytochemicals: from experimental models to clinical trials. World journal of biological chemistry, 7 (1), 88–99.
   PubMedGoogle Scholar
• Meng, L.Q., et al., 2018. Quinalizarin induces apoptosis through reactive oxygen species (ROS)-mediated mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription 3 (STAT3) signaling pathways in colorectal cancer cells. Medical science monitor, 24, 3710–3719.
   PubMed Web of Science ®Google Scholar
• Neupane, S., Bray, F., and Auvinen, A., 2017. National economic and development indicators and international variation in prostate cancer incidence and mortality: an ecological analysis. World journal of urology, 35 (6), 851–858.
   PubMed Web of Science ®Google Scholar
• Peisch, S.F., et al., 2017. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World journal of urology, 35 (6), 867–874.
   PubMed Web of Science ®Google Scholar
• Radisky, E.S., Raeeszadeh-Sarmazdeh, M., and Radisky, D.C., 2017. Therapeutic potential of matrix metalloproteinase inhibition in breast cancer. Journal of cellular biochemistry, 118, 3548–3531.
   Web of Science ®Google Scholar
• Ranjbaran, J., et al., 2016. Matrix metalloproteinases 2 and 9 and MMP9/NGAL complex activity in women with PCOS. Reproduction, 151 (4), 305–311.
   PubMed Web of Science ®Google Scholar
• Shafiee, G., et al., 2016. Genistein induces apoptosis and inhibits proliferation of HT29 colon cancer cells. International journal of molecular and cellular medicine, 5 (3), 178–191.,
   PubMed Web of Science ®Google Scholar
• Shalini, S., et al., 2015. Old, new and emerging functions of caspases. Cell death and differentiation, 22, 526–539.
   PubMed Web of Science ®Google Scholar
• Siegel, R.L., Miller, K.D., and Jemal, A., 2017. Cancer Statistics, 2017. CA: a cancer journal for clinicians, 67 (1), 7–30.
   PubMed Web of Science ®Google Scholar
• Spagnuolo, C., et al., 2015. Genistein and cancer: current status, challenges, and future directions. Advances in nutrition, 6 (4), 408–419.,
   PubMed Web of Science ®Google Scholar
• Su, S.J., et al., 2003. Effects of soy isoflavones on apoptosis induction and G2-M arrestin human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutrition and cancer, 45 (1), 113–123.
   PubMed Web of Science ®Google Scholar
• van de Loosdrecht, A.A., et al., 1994. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. Journal of immunological methods, 174 (1–2), 311–320.
   PubMed Web of Science ®Google Scholar
• Xu, L., and Bergan, R.C., 2006. Genistein inhibits matrix metalloproteinase type 2 activationand prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway. Molecular pharmacology, 70, 869–877.
   PubMed Web of Science ®Google Scholar
• Yazdani, Y., et al., 2016. Genistein suppression of matrix metalloproteinase 2 (MMP-2) and vascular endothelial growth factor (VEGF) expression in mesenchymal stem cell like cells isolated from high and low grade gliomas. Asian pacific journal of cancer prevention: apjcp, 17 (12), 5303–5307.
   PubMedGoogle Scholar
• Zhang, Z., et al., 2018. Genistein promotes ionizing radiation-induced cell death by reducing cytoplasmic Bcl-xL levels in non-small cell lung cancer. Scientific reports, 8 (1), 328.
   PubMed Web of Science ®Google Scholar
• Zhou, H., Chen, J., and Han, J., 2010. Activation of p38 and determination of its activity. Methods in molecular biology, 661, 75–89.
   PubMedGoogle Scholar